The Medicines and Healthcare products Regulatory Agency (MHRA) has launched an educational module that aims to assist health professionals in maximising the benefits and minimising the risks of selective serotonin reuptake inhibitor (SSRI) treatment.
The module notes that SSRIs are the most widely prescribed class of antidepressants. Common and rare adverse effects are identified as well as strategies that minimise and manage the risks. It is suggested that reading will take about two hours and the self assessment test would take about 30 minutes.
Action: Healthcare professionals who prescribe SSRIs will find this a useful resource.
|« Calcipotriol cream discontinued||Prodigy update - December 2011 »|